Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Data Reporting and Recording01:24

Data Reporting and Recording

5.3K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.3K
Statgraphics01:10

Statgraphics

356
Statgraphics is a comprehensive statistical software suite designed for both basic and advanced data analysis. Originating in 1980 at Princeton University under Dr. Neil W. Polhemus, it was one of the pioneering tools for statistical computing on personal computers, with its public release in 1982 marking an early milestone in data science software. Over the years, it has evolved into a robust platform for data science, offering tools for regression analysis, ANOVA, multivariate statistics,...
356
Statistical Analysis System (SAS)01:14

Statistical Analysis System (SAS)

757
SAS, short for Statistical Analysis System, is a powerful data analysis, management, and visualization tool. Developed by the SAS Institute in the early 1970s, SAS has evolved into a comprehensive software suite used across various industries for statistical analysis, business intelligence, and predictive modeling.
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...
757
Introduction to R01:11

Introduction to R

4.0K
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
4.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.3K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proactive drug safety surveillance should be at the heart of the new Health Data Research Service.

BMJ (Clinical research ed.)·2026
Same author

Challenges and Potential Solutions to Advance Global Cancer Drug Development.

Therapeutic innovation & regulatory science·2026
Same author

Innovative oncology trial designs: Time to act - A review with recommendations of the Cancer Drug Development Forum.

Journal of cancer policy·2025
Same author

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management.

Pharmacoepidemiology and drug safety·2025
Same author

Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory Perspective.

Drug safety·2025
Same author

A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a 'Study-A-Thon'.

Therapeutic innovation & regulatory science·2025

Related Experiment Video

Updated: Jan 1, 2026

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.7K

Big Data - How to Realize the Promise.

Alison Cave1, Nikolai C Brun2, Fergus Sweeney1

  • 1European Medicines Agency, Amsterdam, Netherlands.

Clinical Pharmacology and Therapeutics
|December 18, 2019
PubMed
Summary

Regulators face challenges in using big data for healthcare decisions. Ensuring data quality and validity is crucial for confidence in evidence from large datasets.

More Related Videos

A User-friendly and Powerful R Analysis of Large-scale Datasets
10:56

A User-friendly and Powerful R Analysis of Large-scale Datasets

Published on: November 4, 2025

249
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Related Experiment Videos

Last Updated: Jan 1, 2026

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.7K
A User-friendly and Powerful R Analysis of Large-scale Datasets
10:56

A User-friendly and Powerful R Analysis of Large-scale Datasets

Published on: November 4, 2025

249
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Area of Science:

  • Regulatory Science
  • Health Informatics
  • Data Science

Background:

  • Healthcare systems generate vast and complex big data from diverse sources.
  • Big data offers potential for improved disease, treatment, and medicinal product characterization.
  • Regulatory acceptance requires understanding data provenance, quality, and analytical methods.

Purpose of the Study:

  • To explore the big data landscape from a regulatory perspective.
  • To identify challenges in using big data for regulatory decision-making.
  • To establish criteria for regulatory confidence in big data evidence.

Main Methods:

  • Review of the initial phase of the Heads of Agencies and European Medicines Agency Joint Big Data Taskforce.
  • Analysis of the regulatory implications of big data characteristics.
  • Identification of key considerations for data validation and analysis.

Main Results:

  • Big data presents opportunities but also significant challenges for regulatory bodies.
  • Establishing confidence in big data requires robust frameworks for data quality and provenance.
  • New methods for processing and analyzing big data need validation.

Conclusions:

  • Regulators need clear guidelines to assess and trust evidence derived from big datasets.
  • Addressing data quality, provenance, and analytical validity is paramount.
  • The Joint Big Data Taskforce aims to provide a regulatory framework for big data utilization.